logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8772229 B1

PDFFull Text
Expired
Date of Patent:
Jul. 08, 2014

Filed:

Sep. 18, 2009

Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes

Applicants:

Philip A. Cole, Baltimore, MD (US);

Bradley P. Barnett, Baltimore, MD (US);

Yousang Hwang, Baltimore, MD (US);

Jef D. Boeke, Baltimore, MD (US);

Inventors:

Philip A. Cole, Baltimore, MD (US);

Bradley P. Barnett, Baltimore, MD (US);

Yousang Hwang, Baltimore, MD (US);

Jef D. Boeke, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorneys:

Venable LLP

Stefan J. Kirchanski

Primary Examiner:

Maury Audet

Assistant Examiner:

Zachary J Miknis

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61P 3/04 (2006.01); A61K 38/28 (2006.01); A61P 3/10 (2006.01); A61P 7/12 (2006.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); A61K 38/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides inhibitors of ghrelin O-acyltransferase, and methods of making and using them. In some embodiments, the invention provides bisubstrate analog inhibitors of ghrelin O-acyltransferase, which can be effective in treating, for example, obesity and diabetes mellitus.

Find Patent Forward Citations

Cole, Philip. (2014). Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes (U.S. Patent No. 8772229). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8772229

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…